Bioxytran Inc
(BIXT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5 | 0 | 23 | 0 | 3 |
| Receivables | 2 | N/A | 36 | N/A | N/A |
| Inventories | 7 | N/A | 6 | 6 | 6 |
| TOTAL | $14 | $0 | $65 | $6 | $9 |
| Non-Current Assets | |||||
| PPE Net | 678 | N/A | 12 | 16 | 20 |
| TOTAL | $678 | $N/A | $12 | $16 | $20 |
| Total Assets | $692 | $0 | $77 | $22 | $29 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 45 | 1 | 304 | 299 | 271 |
| Accrued Expenses | 27 | N/A | 33 | 31 | 29 |
| Other current liabilities | 27 | N/A | 5 | 5 | 5 |
| TOTAL | $179 | $1 | $422 | $415 | $384 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $179 | $1 | $422 | $415 | $384 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 107,436 | 105,416 | 34,916 | 34,916 | 34,916 |
| Common Shares | 105 | 85 | 35 | 35 | 24 |
| Retained earnings | -14,231 | -86 | -14,159 | -14,208 | -13,947 |
| TOTAL | $513 | $-1 | $-345 | $-394 | $-355 |
| Total Liabilities And Equity | $692 | $0 | $77 | $22 | $29 |